You are here
Arkansas Governor's Newsletter March 2018
In this Issue:
- Governor's Message
- Join Us in New Orleans! IM 2018 AR Dinner and Reception
- Save the Date!
- Feedback Requested
- ACP Awarded Grant to Help Combat Nation's Opioid Crisis
- ACP's Public Policy Development Process
- ACP Recommends Moderate Blood Sugar Control Targets for Most Patients with Type 2 Diabetes
Omar T. Atiq, MD, FACP, ACP Governor
Dear Fellow ACP members,
IM 2018 is right around the corner - April 19 - 21, 2018. This year we can drive down to New Orleans to attend it rather than having to fly to a distant city as in the past years. So, I am hoping that we will have a large Arkansas delegation at the meeting. I will be representing you at the Board of Governors meeting earlier that week. Two of the resolutions that will be discussed and debated about ABIM MOC and ACP representation at the AMA have been sponsored by our Chapter. Please review the resolutions at the ACP Arkansas Chapter website and give your input and comments.
Our Chapter's famed Reading Retreat at The Red Apple Inn on Eden Isle, Heber Springs, will take place on April 7 - 8, 2018, under the able leadership of Dr. Eric del Giacco. On May 22nd - 23rd, the ACP Leadership Day will be held in Washington, DC. It is a wonderful experience allowing our members to interact with our legislators and their staff on behalf of our patients. I highly recommend it. Our Annual Chapter Scientific Meeting will be held in Little Rock on September 7 - 8, 2018. Dr. Stacy Zimmerman and Dr. Keyur Vyas are planning an informative and exciting educational program. Please mark your calendars.
ACP continues its tremendous efforts to improve health care delivery and physician well-being in our country. ACP's Patients Before Paperwork initiative focuses on reinvigorating the patient-physician relationship by challenging administrative burdens that physicians face in practice. I request you to continue to be ambassadors for ACP and keep spreading the good word among fellow internists, sub specialists, residents and medical students.
I hope you have a wonderful spring and summer. I look forward to seeing you in one of our meetings.
Omar T. Atiq, MD, FACP
Governor, Arkansas Chapter
American College of Physicians
Join Us in New Orleans! IM 2018 AR Dinner and Reception
The Arkansas Chapter Dinner will be on Thursday, April 19th at 8:00 P.M. The venue is TBD at this time. Please RSVP and we will send you all information.
The AR reception will be held on Friday, April 20, 2018 @ 5:30pm at the New Orleans Marriott, Studio 4 Room 555 Canal Street, New Orleans, LA 70130
RSVP for IM 2018 Dinner and Reception HERE
Save the Date!
The Arkansas Chapter Meeting will be held on September 7th and 8th in Little Rock! This year's meeting will be held at the Double Tree by Hilton Little Rock, 424 West Markham Street. More information to follow.
We would like to request your feedback regarding the 23 resolutions that will be heard at the spring 2018 Board of Governors Meeting. The resolutions have been posted on the chapter's Web site for your review Please send your comments indicating whether or not you support a resolution by using this form: ACP AR Resolution Feedback
ACP Awarded Grant to Help Combat Nation's Opioid Crisis
ACP received a $50,000 sub-award from the American Academy of Addiction Psychiatry (AAAP) to help combat the nation's opioid crisis.
ACP's role will be to support recruitment of ACP members to work with AAAP's coalition and to identify local medical champions.
In March 2017, ACP released a position paper, “Health and Public Policy to Facilitate Effective Prevention and Treatment of Substance Use Disorders Involving Illicit and Prescription Drugs “
ACP's Public Policy Development Process
Ever wonder how ACP public policy is developed? Information regarding ACP's public policy development process is available online.
ACP Recommends Moderate Blood Sugar Control Targets for Most Patients with Type 2 Diabetes
ACP has published an evidence-based guidance statement in Annals of Internal Medicine to guide clinicians in selecting A1C targets for pharmacologic treatment of type 2 diabetes.